FDA clears software, MRI coil, and scanner
Several products have gained clearance for marketing in the U.S. Passing FDA muster were Vital Images' Vscore, a cardiac CT option featuring AutoGate for use on the company's Vitrea 2 workstation; Surgi-Vision's intravascular MRI coil; and Marconi's
Several products have gained clearance for marketing in the U.S. Passing FDA muster were Vital Images' Vscore, a cardiac CT option featuring AutoGate for use on the company's Vitrea 2 workstation; Surgi-Vision's intravascular MRI coil; and Marconi's Infinion 1.5T MRI scanner. Vital Images' VScore with AutoGate determines the phase of the cardiac cycle at which each CT slice was recorded, automatically selecting the images of the heart least affected by cardiac motion without an ECG signal. Called Intercept, the disposable coil from Surgi-Vision is designed to be threaded into arteries or veins to detect early signs of blood vessel disease in conjunction with standard MRI scanners. Infinion 1.5T is a short-bore whole-body MRI system.
2/28/01, Issue # 1504, page 6.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
